Abstract
Introduction

40
Acquisition of mutations is a ubiquitous and essential feature of the cells of living organisms.
41
Although there has been comprehensive characterisation of the somatic mutation landscape 42 of human cancer [1] [2] [3] , understanding of patterns of somatic mutation in normal cells is limited.
43
In large part this has been due to the challenge of detecting somatic mutations in normal
44
tissues and several strategies have recently been developed to address this including 45 sequencing of in vitro derived clonal cell populations from normal tissues [4] [5] [6] [7] [8] , sequencing
46
small biopsies containing limited numbers of microscopic clones 9,10 , sequencing 47 microscopically distinguishable structural elements which are clonal units 11, 12 , highly error corrected sequencing 13, 14 and sequencing single cells 15, 16 
57
The factors determining differences in mutation landscape between normal cell types are 58 incompletely understood. However, they plausibly include the intrinsic structural and 
66
basal glands retained after menstruation [22] [23] [24] [25] .
68
Characterisation of the mutational landscapes of normal tissues is beginning to provide 69 
81
In addition to endometrial glands, nearby normal endocervical glands were microdissected 146 from one individual (PD37506). There was a ~2-fold lower somatic mutation burden in 147 endocervical than endometrial glands (Extended Data Fig. 3 ). This may reflect the absence,
148
in endocervical glands, of the cyclical process of loss and regeneration that occurs in 149 endometrial glands.
151
Mutational signatures
152
To explore the underlying processes of somatic mutagenesis operative in normal
153
endometrial epithelial cells mutational signatures were analysed. Three previously described 
172
Somatic copy number changes and structural variants (genome rearrangements) were found 173 in only 27 out of 182 (15%) normal endometrial glands (Fig. 2c, Supplementary Results 3) .
174
These included copy number neutral loss of heterozygosity (cnn LOH) in six glands, whole 175 chromosome copy number increases in one and structural variants in eighteen (12 large 176 deletions, six tandem duplications and nine translocations). 
226
WNT signalling (FBXW7) and proteins involved in chromatin function (KMT2D, ARID5B).
227
Many different combinations of mutated cancer genes were found in individual glands.
229
Driver mutations were placed on the phylogenetic trees of somatic mutations constructed for 230 each individual and, by assuming a constant somatic mutation rate during life, the time of 231 occurrence of a subset was estimated (Methods). Some driver mutations occurred early in 232 life. These included a KRAS G12D mutation in three glands from a 35 year old and a
233
PIK3CA mutation in two glands from a 34 year old, which are both likely to have arisen 
284
There were also differences in the repertoire of cancer genes in which driver mutations were 285 found (Fig 5 d, 
593
There was a ~2-fold difference in the mutation burden between the two types of glands.
595
Extended 
650
Cohorts 4 and 5: Samples from individuals PD37506, PD38812, PD37507 and PD40659
651
(age 19 to 81) were obtained at autopsy following death from non-gynaecological causes.
652
The use of this material was approved by the London, Surrey Research Ethics Committee 
656
All endometrial biopsies underwent formal pathology review, which confirmed benign 657 histology.
659
Laser-capture microdissection of endometrial glands
660
Frozen and paraffin sections were used for laser-capture microdissection (LCM 
687
for 60 minutes at 50°C and 30 minutes at 75°C prior to storage at -80°C.
689
All samples in this study were processed using our recently developed low-input enzymatic 
731
(cervix, myometrium, Fallopian tube or endometrial stroma) were used to run the algorithm.
733
A set of previously described post-processing filters were subsequently applied:
734 735
(1) to remove common single nucleotide polymorphisms, variants were filtered against a 
775
Indels
776
Insertions and deletions were called using cgpPindel 43, 44 . To remove germline variants the 777 algorithm was run with the same matched normal samples that were used for calling 778 substitutions. Post-processing filters were applied as previously described 42 . In addition, a
779
'Qual' filter (the sum of the mapping qualities of the supporting reads) of at least 300 and a
780
depth cut-off of at least 15 reads were used.
782
Copy number variants and structural variants
783
Allele-specific copy number profiles were reconstructed for the endometrial gland samples
784
by ASCAT 45,46 using matched samples as described above, ploidy of 2 and contamination
785
with other cell types of 10%. Only samples with a minimum coverage of 15X and above
786
were used. All putative copy number changes were visually inspected for copy number 787 profiles on Jbrowse 47 .
789
Structural variants (SVs) in endometrial glands were called using matched samples (as 
879
Detection of driver mutations
880
Analysis of driver variants in the normal endometrial glands was performed in two parts. 
To compare patterns of selection in normal endometrial epithelium and cancer, we 910 performed dNdS analysis on publicly available calls from the The Cancer Genome Atlas,
911
TCGA.
913
Phylogenetic tree reconstruction
914
Phylogenies for endometrial glands were reconstructed for seventeen donors. Due to the 915 low number of available samples, donor PD38812 was not included in this analysis. We first 916 generated trees using substitutions called by CaVEMan; matched normal samples were 917 used to exclude germline variants and post-processing filters were applied as above. Final
918
variants were recalled in all samples from each donor using an in-house re-genotyping 919 algorithm (cgpVAF). Variants with a VAF>0.3 were noted to be present ('1'), VAF<0.1 absent ('0') and between 0.1 and 0.3 as ambiguous ('?'). This approach excludes private sub-clonal 921 variants from the tree building. The tree was reconstructed using a maximum parsimony 922 approach 48 and branch support was calculated using 1000 bootstrap replicates. Nodes with 923 a confidence lower than 50 were collapsed into polytomies and branch lengths of the 924 collapsed tree were determined by the number of assigned substitutions.
926
The constructed phylogenies were validated using indels called by Pindel and filtered as 927 above. The same approach was applied for the final indel matrices. Although the lower 928 number of indels resulted in more polytomous tree, the overall tree topologies were 929 reconcilable with those generated using substitutions.
931
Cancer driver mutations, copy number and structural variants were annotated manually in 932 the trees.
934
Mutational signature analysis
935
Mutational signature extraction was performed using mutations assigned to every branch of 936 the reconstructed phylogenetic trees and each branch was treated as an individual sample.
937
Such approach allows characterisation and differentiation of specific mutational processes 938 that were operative at various times in individual glands. 
942
(https://github.com/nicolaroberts/hdp) that utilises hierarchical Bayesian Dirichlet process.
943
Code and the input mutations are available at https://github.com/LuizaMoore/Endometrium.
944
SBS signature analysis was performed in 3 steps: extraction, deconvolution and re- 
951
(parameter 'burnin'), with a spacing of 500 iterations (parameter 'space') and 250
952
samples/iterations were collected (parameter 'n'). After each Gibbs sampling iteration, 3
953
iterations of concentration parameter sampling were performed (parameter 'cpiter') and 954 components were extracted (Cos merge 0.9, sample 2).
956
Two reference signatures were extracted: SBS1 (P1, cosine similarity 0.997) and SBS5 (P5, 
967
Indels were classified using PCAWG method 2 and composite mutational spectra were 969 generated for each donor. However, given the relatively low numbers of indels, no formal 970 signature extraction was performed.
972
Calculations of mutation burden and estimation of mutation rate
974
To account for the non-independent sampling per patient we used mixed effects models. We 975 tested features with a known effect on mutation burden or endometrial cancer risk; age,
976
Read depth & VAF, BMI and Parity. All statistical analyses were performed in R and are 977 summarised in the Supplementary Results.
979 980
Data availability
981
Whole genome sequencing data are deposited in the European Genome 715 Phenome
982
Archive (EGA) with accession number 716 EGAS00001002471.
984 985
Code availability
986
Code for statistical analyses on total substitution and driver mutation burdens is included in 
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